At a glance
ClinicalIndex Comparison RecordN/ACompleted· 170 enrolled
Drug / intervention
Suboxone +3 moredrug
Likely dose
Suboxone 18 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy of Computer Delivered CRA (Bup II) Grant No. R01DA012997-10
Virginia Polytechnic Institute and State University·interventional·Posted Jun 29, 2009·Updated May 27, 2022
In Brief
A clinical study evaluating Suboxone, CRA, and 2 other interventions for Opiate Addiction. Completed, enrolled 170 participants across 1 site.
Detailed Summary
This study is designed to examine the effects of combined buprenorphine and voucher incentives to promote abstinence from illicit opiate use, along with or without computer-delivered therapy, during treatment of opioid dependence.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOpiate Addiction
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartSep 2007
First PostedJun 2009
Primary CompletionApr 2010
TodayJul 2026
First PostedJun 29, 2009
Enrollment StartSep 1, 2007
Primary CompletionApr 1, 2010
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 17.0 years ago
Interventions
Suboxonedrug
Dosage Form: Oral Tablet; Dosage 6, 12, or 18 mg; Frequency; Daily; Duration 12 weeks
CRAbehavioral
Computer-delivered Community Reinforcement Approach
Therapybehavioral
Therapist-delivered therapy
CMbehavioral
Contingency management (vouchers) for providing a drug negative urine sample.